<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34848203</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-016X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>234</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pharmacology &amp; therapeutics</Title>
          <ISOAbbreviation>Pharmacol Ther</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization.</ArticleTitle>
        <Pagination>
          <StartPage>108048</StartPage>
          <MedlinePgn>108048</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pharmthera.2021.108048</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0163-7258(21)00250-3</ELocationID>
        <Abstract>
          <AbstractText>Translocator Protein 18 kDa (TSPO), previously named Peripheral Benzodiazepine Receptor, is a well-validated and widely used biomarker of neuroinflammation to assess diverse central nervous system (CNS) pathologies in preclinical and clinical studies. Many studies have shown that in animal models of human neurological and neurodegenerative disease and in the human condition, TSPO levels increase in the brain neuropil, and this increase is driven by infiltration of peripheral inflammatory cells and activation of glial cells. Therefore, a clear understanding of the dynamics of the cellular sources of the TSPO response is critically important in the interpretation of Positron Emission Tomography (PET) studies and for understanding the pathophysiology of CNS diseases. Within the normal brain compartment, there are tissues and cells such as the choroid plexus, ependymal cells of the lining of the ventricles, and vascular endothelial cells that also express TSPO at even higher levels than in glial cells. However, there is a paucity of knowledge if these cell types respond and increase TSPO in the diseased brain. These cells do provide a background signal that needs to be accounted for in TSPO-PET imaging studies. More recently, there are reports that TSPO may be expressed in neurons of the adult brain and TSPO expression may be increased by neuronal activity. Therefore, it is essential to study this topic with a great deal of detail, methodological rigor, and rule out alternative interpretations and imaging artifacts. High levels of TSPO are present in the outer mitochondrial membrane. Recent studies have provided evidence of its localization in other cellular compartments including the plasma membrane and perinuclear regions which may define functions that are different from that in mitochondria. A greater understanding of the TSPO subcellular localization in glial cells and infiltrating peripheral immune cells and associated function(s) may provide an additional layer of information to the understanding of TSPO neurobiology. This review is an effort to outline recent advances in understanding the cellular sources and subcellular localization of TSPO in brain cells and to examine remaining questions that require rigorous investigation.</AbstractText>
          <CopyrightInformation>Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Guilarte</LastName>
            <ForeName>Tomás R</ForeName>
            <Initials>TR</Initials>
            <AffiliationInfo>
              <Affiliation>Brain, Behavior, &amp; the Environment Program, Department of Environmental Health Sciences, Robert Stempel College of Public Health &amp; Social Work, Florida International University, Miami, FL 33199, United States of America. Electronic address: tguilart@fiu.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodichkin</LastName>
            <ForeName>Alexander N</ForeName>
            <Initials>AN</Initials>
            <AffiliationInfo>
              <Affiliation>Brain, Behavior, &amp; the Environment Program, Department of Environmental Health Sciences, Robert Stempel College of Public Health &amp; Social Work, Florida International University, Miami, FL 33199, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McGlothan</LastName>
            <ForeName>Jennifer L</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>Brain, Behavior, &amp; the Environment Program, Department of Environmental Health Sciences, Robert Stempel College of Public Health &amp; Social Work, Florida International University, Miami, FL 33199, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Acanda De La Rocha</LastName>
            <ForeName>Arlet Maria</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Brain, Behavior, &amp; the Environment Program, Department of Environmental Health Sciences, Robert Stempel College of Public Health &amp; Social Work, Florida International University, Miami, FL 33199, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Azzam</LastName>
            <ForeName>Diana J</ForeName>
            <Initials>DJ</Initials>
            <AffiliationInfo>
              <Affiliation>Brain, Behavior, &amp; the Environment Program, Department of Environmental Health Sciences, Robert Stempel College of Public Health &amp; Social Work, Florida International University, Miami, FL 33199, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 ES007062</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>27</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pharmacol Ther</MedlineTA>
        <NlmUniqueID>7905840</NlmUniqueID>
        <ISSNLinking>0163-7258</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018079">Receptors, GABA</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C499229">TSPO protein, human</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018079" MajorTopicYN="Y">Receptors, GABA</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Astrocytes</Keyword>
        <Keyword MajorTopicYN="N">Confocal imaging</Keyword>
        <Keyword MajorTopicYN="N">Microglia</Keyword>
        <Keyword MajorTopicYN="N">Neuroinflammation</Keyword>
        <Keyword MajorTopicYN="N">Positron emission tomography - immunofluorescence</Keyword>
        <Keyword MajorTopicYN="N">Translocator protein 18 kDa (TSPO)</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of Competing Interest The authors declare that there are no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2022</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34848203</ArticleId>
        <ArticleId IdType="mid">NIHMS1762870</ArticleId>
        <ArticleId IdType="pmc">PMC9107500</ArticleId>
        <ArticleId IdType="doi">10.1016/j.pharmthera.2021.108048</ArticleId>
        <ArticleId IdType="pii">S0163-7258(21)00250-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Adamsky A, Kol A, Kreisel T, Doron A, Ozeri-Engelhard N, Melcer T, … Goshen I (2018). Astrocytic activation generates de novo neuronal potentiation and memory enhancement. Cell
174(59–71), Article e14.</Citation>
        </Reference>
        <Reference>
          <Citation>Alam MM, Lee J, &amp; Lee SY (2017). Recent progress in the development of TSPO PET ligands for neuroinflammation imaging in neurological diseases. Nuclear Medicine and Molecular Imaging
51, 283–296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5721086</ArticleId>
            <ArticleId IdType="pubmed">29242722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alho H, Varga V, &amp; Krueger KE (1994). Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: Relation to cell growth. Cell Growth &amp; Differentiation
5, 1005–1014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7819126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anholt RR, Pedersen PL, De Souza EB, &amp; Snyder SH (1986). The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem
261, 576–583.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3001071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batoko H, Veljanovski V, &amp; Jurkiewicz P (2015). Enigmatic translocator protein (TSPO) and cellular stress regulation. Trends in Biochemical Sciences
40, 497–503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26228316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Betlazar C, Harrison-Brown M, Middleton RJ, Banati R, &amp; Liu GJ (2018). Cellular sources and regional variations in the expression of the neuroinflammatory marker translocator protein (TSPO) in the normal brain. International Journal of Molecular Sciences
19.</Citation>
        </Reference>
        <Reference>
          <Citation>Blevins LK, Crawford RB, Azzam DJ, Guilarte TR, &amp; Kaminski NE (2020). Surface translocator protein 18 kDa (TSPO) localization on immune cells upon stimulation with LPS and in ART-treated HIV(+) subjects. Journal of Leukocyte Biology
110(1), 123–140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8126641</ArticleId>
            <ArticleId IdType="pubmed">33205494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonsack F. t., Alleyne CH Jr., &amp; Sukumari-Ramesh S (2016). Augmented expression of TSPO after intracerebral hemorrhage: A role in inflammation?
Journal of Neuroinflammation
13, 151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4912814</ArticleId>
            <ArticleId IdType="pubmed">27315802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boujrad N, Vidic B, Gazouli M, Culty M, &amp; Papadopoulos V (2000). The peroxisome proliferator perfluorodecanoic acid inhibits the peripheral-type benzodiazepine receptor (PBR) expression and hormone-stimulated mitochondrial cholesterol transport and steroid formation in Leydig cells. Endocrinology
141, 3137–3148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10965884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boujrad N, Vidic B, &amp; Papadopoulos V (1996). Acute action of choriogonadotropin on Leydig tumor cells: Changes in the topography of the mitochondrial peripheraltype benzodiazepine receptor. Endocrinology
137, 5727–5730.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8940407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen MK, Baidoo K, Verina T, &amp; Guilarte TR (2004). Peripheral benzodiazepine receptor imaging in CNS demyelination: Functional implications of anatomical and cellular localization. Brain
127, 1379–1392.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15069023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen MK, &amp; Guilarte TR (2008). Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair. Pharmacology &amp; Therapeutics
118, 1–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2453598</ArticleId>
            <ArticleId IdType="pubmed">18374421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi J, Ifuku M, Noda M, &amp; Guilarte TR (2011). Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state. Glia
59, 219–230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4425360</ArticleId>
            <ArticleId IdType="pubmed">21125642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colasanti A, Owen DR, Grozeva D, Rabiner EA, Matthews PM, Craddock N, &amp; Young AH (2013). Bipolar disorder is associated with the rs6971 polymorphism in the gene encoding 18 kDa translocator protein (TSPO). Psychoneuroendocrinology
38, 2826–2829.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3820042</ArticleId>
            <ArticleId IdType="pubmed">23942012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costa B, Pini S, Gabelloni P, Da Pozzo E, Abelli M, Lari L, … Martini C (2009). The spontaneous Ala147Thr amino acid substitution within the translocator protein influences pregnenolone production in lymphomonocytes of healthy individuals. Endocrinology
150, 5438–5445.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19846611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costa B, Pini S, Martini C, Abelli M, Gabelloni P, Landi S, … Cassano GB (2009). Ala147Thr substitution in translocator protein is associated with adult separation anxiety in patients with depression. Psychiatric Genetics
19, 110–111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19668118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delavoie F, Li H, Hardwick M, Robert JC, Giatzakis C, Peranzi G, … Papadopoulos V (2003). In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: Functional significance in drug ligand and cholesterol binding. Biochemistry
42, 4506–4519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12693947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Desai R, East DA, Hardy L, Faccenda D, Rigon M, Crosby J, … Campanella M (2020). Mitochondria form contact sites with the nucleus to couple prosurvival retrograde response. Science Advances
6.</Citation>
        </Reference>
        <Reference>
          <Citation>Edling Y, Ingelman-Sundberg M, &amp; Simi A (2007). Glutamate activates c-fos in glial cells via a novel mechanism involving the glutamate receptor subtype mGlu5 and the transcriptional repressor DREAM. Glia
55, 328–340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17120244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan J, &amp; Papadopoulos V (2020). Mitochondrial TSPO deficiency triggers retrograde Signaling in MA-10 mouse tumor Leydig cells. International Journal of Molecular Sciences
22.</Citation>
        </Reference>
        <Reference>
          <Citation>Focke C, Blume T, Zott B, Shi Y, Deussing M, Peters F, … Brendel M (2019). Early and longitudinal microglial activation but not amyloid accumulation predicts cognitive outcome in PS2APP mice. Journal of Nuclear Medicine
60, 548–554.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30262517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujimoto M, &amp; Hayashi T (2011). New insights into the role of mitochondria-associated endoplasmic reticulum membrane. International Review of Cell and Molecular Biology
292, 73–117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22078959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gatliff J, East DA, Singh A, Alvarez MS, Frison M, Matic I, … Campanella M (2017). A role for TSPO in mitochondrial Ca(2+) homeostasis and redox stress signaling. Cell Death &amp; Disease
8, Article e2896.</Citation>
        </Reference>
        <Reference>
          <Citation>Gong J, Szego EM, Leonov A, Benito E, Becker S, Fischer A, … Schneider A (2019). Translocator protein ligand protects against neurodegeneration in the MPTP mouse model of parkinsonism. The Journal of Neuroscience
39, 3752–3769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6510339</ArticleId>
            <ArticleId IdType="pubmed">30796158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gui Y, Marks JD, Das S, Hyman BT, &amp; Serrano-Pozo A (2020). Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer’s disease brains. Brain Pathology
30, 151–164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6904423</ArticleId>
            <ArticleId IdType="pubmed">31276244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guilarte TR (2019). TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward. Pharmacology &amp; Therapeutics
194, 44–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6348013</ArticleId>
            <ArticleId IdType="pubmed">30189290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guilarte TR, Loth MK, &amp; Guariglia SR (2016). TSPO finds NOX2 in microglia for redox homeostasis. Trends in Pharmacological Sciences
37, 334–343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5042807</ArticleId>
            <ArticleId IdType="pubmed">27113160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hiser C, Montgomery BL, &amp; Ferguson-Miller S (2021). TSPO protein binding partners in bacteria, animals, and plants. Journal of Bioenergetics and Biomembranes
53, 463–487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8243069</ArticleId>
            <ArticleId IdType="pubmed">34191248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hung AC, Huang HM, Tsay HJ, Lin TN, Kuo JS, &amp; Sun SH (2000). ATP-stimulated c-fos and zif268 mRNA expression is inhibited by chemical hypoxia in a rat brainderived type 2 astrocyte cell line, RBA-2. Journal of Cellular Biochemistry
77, 323–332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10723097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Issop L, Fan J, Lee S, Rone MB, Basu K, Mui J, &amp; Papadopoulos V (2015). Mitochondria-associated membrane formation in hormone-stimulated Leydig cell steroidogenesis: Role of ATAD3. Endocrinology
156, 334–345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25375035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Issop L, Ostuni MA, Lee S, Laforge M, Peranzi G, Rustin P, … Lacapere JJ (2016). Translocator protein-mediated stabilization of mitochondrial architecture during inflammation stress in colonic cells. PLoS One
11, Article e0152919.</Citation>
        </Reference>
        <Reference>
          <Citation>Jaipuria G, Leonov A, Giller K, Vasa SK, Jaremko L, Jaremko M, … Zweckstetter M (2017). Cholesterol-mediated allosteric regulation of the mitochondrial translocator protein structure. Nature Communications
8, 14893.</Citation>
        </Reference>
        <Reference>
          <Citation>Ji B, Ono M, Yamasaki T, Fujinaga M, Zhang MR, Seki C, … Higuchi M (2021). Detection of Alzheimer’s disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein. Journal of Cerebral Blood Flow and Metabolism
41, 2076–2089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8327108</ArticleId>
            <ArticleId IdType="pubmed">33557690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Junck L, Olson JM, Ciliax BJ, Koeppe RA, Watkins GL, Jewett DM, … Starosta Rubinstein S, et al. (1989). PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Annals of Neurology
26, 752–758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2557794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang Y, Pandya S, Zinger N, Michaelson N, &amp; Gauthier SA (2021). Longitudinal change in TSPO PET imaging in progressive multiple sclerosis. Annals of Clinical Translational Neurology
8, 1755–1759.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8351399</ArticleId>
            <ArticleId IdType="pubmed">34310086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim K, Kim H, Bae SH, Lee SY, Kim YH, Na J, … Youn H (2020). [(18)F]CB251 PET/ MR imaging probe targeting translocator protein (TSPO) independent of its polymorphism in a neuroinflammation model. Theranostics
10, 9315–9331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7415805</ArticleId>
            <ArticleId IdType="pubmed">32802194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korkhov VM, Sachse C, Short JM, &amp; Tate CG (2010). Three-dimensional structure of TspO by electron cryomicroscopy of helical crystals. Structure
18, 677–687.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2911597</ArticleId>
            <ArticleId IdType="pubmed">20541505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kreisl WC, Kim MJ, Coughlin JM, Henter ID, Owen DR, &amp; Innis RB (2020). PET imaging of neuroinflammation in neurological disorders. Lancet Neurology
19, 940–950.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7912433</ArticleId>
            <ArticleId IdType="pubmed">33098803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krueger KE, &amp; Papadopoulos V (1990). Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. The Journal of Biological Chemistry
265, 15015–15022.</Citation>
        </Reference>
        <Reference>
          <Citation>Kuhlmann AC, &amp; Guilarte TR (2000). Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. Journal of Neurochemistry
74, 1694–1704.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10737628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwon HS, &amp; Koh SH (2020). Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes. Transl Neurodegener
9, 42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7689983</ArticleId>
            <ArticleId IdType="pubmed">33239064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lacapere JJ, Delavoie F, Li H, Peranzi G, Maccario J, Papadopoulos V, &amp; Vidic B (2001). Structural and functional study of reconstituted peripheral benzodiazepine receptor. Biochemical and Biophysical Research Communications
284, 536–541.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11394915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lacapere JJ, &amp; Papadopoulos V (2003). Peripheral-type benzodiazepine receptor: Structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids
68, 569–585.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12957662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lahooti B, Chhibber T, Bagchi S, Varahachalam SP, &amp; Jayant RD (2021). Therapeutic role of inflammasome inhibitors in neurodegenerative disorders. Brain, Behavior, and Immunity
91, 771–783.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33157255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li F, Liu J, Garavito RM, &amp; Ferguson-Miller S (2015). Evolving understanding of translocator protein 18 kDa (TSPO). Pharmacological Research
99, 404–409.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4567528</ArticleId>
            <ArticleId IdType="pubmed">25882248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li F, Liu J, Liu N, Kuhn LA, Garavito RM, &amp; Ferguson-Miller S (2016). Translocator protein 18 kDa (TSPO): An old protein with new functions?
Biochemistry
55, 2821–2831.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5125027</ArticleId>
            <ArticleId IdType="pubmed">27074410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loth MK, Guariglia SR, Re DB, Perez J, de Paiva VN, Dziedzic JL, … Guilarte TR (2020). A novel interaction of translocator protein 18 kDa (TSPO) with NADPH oxidase in microglia. Molecular Neurobiology
57, 4467–4487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7515859</ArticleId>
            <ArticleId IdType="pubmed">32743737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mattner F, Katsifis A, Bourdier T, Loc’h C, Berghofer P, Fookes C, … Fulham M (2021). Synthesis and pharmacological evaluation of [(18)F]PBR316: A novel PET ligand targeting the translocator protein 18 kDa (TSPO) with low binding sensitivity to human single nucleotide polymorphism rs6971. RSC Med Chem
12, 1207–1221.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8292990</ArticleId>
            <ArticleId IdType="pubmed">34355185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meyer JH, Cervenka S, Kim MJ, Kreisl WC, Henter ID, &amp; Innis RB (2020). Neuroinflammation in psychiatric disorders: PET imaging and promising new targets. Lancet Psychiatry
7, 1064–1074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7893630</ArticleId>
            <ArticleId IdType="pubmed">33098761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morohaku K, Pelton SH, Daugherty DJ, Butler WR, Deng W, &amp; Selvaraj V (2014). Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology
155, 89–97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3868810</ArticleId>
            <ArticleId IdType="pubmed">24174323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mukhin AG, Papadopoulos V, Costa E, &amp; Krueger KE (1989). Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proceedings of the National Academy of Sciences of the United States of America
86, 9813–9816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC298592</ArticleId>
            <ArticleId IdType="pubmed">2574864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nack A, Brendel M, Nedelcu J, Daerr M, Nyamoya S, Beyer C, … Kipp M (2019). Expression of translocator protein and [18F]-GE180 ligand uptake in multiple sclerosis animal models. Cells
8.</Citation>
        </Reference>
        <Reference>
          <Citation>Niklison-Chirou MV, Agostini M, Amelio I, &amp; Melino G (2020). Regulation of adult neurogenesis in mammalian brain. International Journal of Molecular Sciences
21.</Citation>
        </Reference>
        <Reference>
          <Citation>Notter T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M, … Meyer U (2018). Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Molecular Psychiatry
23, 323–334.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28093569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Notter T, Schalbetter SM, Clifton NE, Mattei D, Richetto J, Thomas K, … Hall J (2020). Neuronal activity increases translocator protein (TSPO) levels. Molecular Psychiatry
26(6), 2025–2037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8440208</ArticleId>
            <ArticleId IdType="pubmed">32398717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nutma E, Stephenson JA, Gorter RP, de Bruin J, Boucherie DM, Donat CK, … Amor S (2019). A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis. Brain
142, 3440–3455.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6821167</ArticleId>
            <ArticleId IdType="pubmed">31578541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oke BO, Suarez-Quian CA, Riond J, Ferrara P, &amp; Papadopoulos V (1992). Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex. Molecular and Cellular Endocrinology
87, R1–R6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1332905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olson JM, Ciliax BJ, Mancini WR, &amp; Young AB (1988). Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes. European Journal of Pharmacology
152, 47–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2850202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Owen DR, Narayan N, Wells L, Healy L, Smyth E, Rabiner EA, … Moore CS (2017). Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans. Journal of Cerebral Blood Flow and Metabolism
37, 2679–2690.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5536262</ArticleId>
            <ArticleId IdType="pubmed">28530125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, … Rubio JP (2012). An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. Journal of Cerebral Blood Flow and Metabolism
32, 1–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3323305</ArticleId>
            <ArticleId IdType="pubmed">22008728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paillusson S, Stoica R, Gomez-Suaga P, Lau DHW, Mueller S, Miller T, &amp; Miller CCJ (2016). There’s something wrong with my MAM; the ER-mitochondria axis and neurodegenerative diseases. Trends in Neurosciences
39, 146–157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4780428</ArticleId>
            <ArticleId IdType="pubmed">26899735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pannell M, Economopoulos V, Wilson TC, Kersemans V, Isenegger PG, Larkin JR, … Sibson NR (2020). Imaging of translocator protein upregulation is selective for proinflammatory polarized astrocytes and microglia. Glia
68, 280–297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6916298</ArticleId>
            <ArticleId IdType="pubmed">31479168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papadopoulos V, Amri H, Boujrad N, Cascio C, Culty M, Garnier M, … Drieu K (1997). Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids
62, 21–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9029710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pappata S, Cornu P, Samson Y, Prenant C, Benavides J, Scatton B, … Syrota A (1991). PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: A case report. Journal of Nuclear Medicine
32, 1608–1610.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1651383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reeber SL, Arancillo M, &amp; Sillitoe RV (2018). Bergmann glia are patterned into topographic molecular zones in the developing and adult mouse cerebellum. Cerebellum
17, 392–403.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4291305</ArticleId>
            <ArticleId IdType="pubmed">24906823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Refaeli R, Doron A, Benmelech-Chovav A, Groysman M, Kreisel T, Loewenstein Y, &amp; Goshen I (2021). Features of hippocampal astrocytic domains and their spatial relation to excitatory and inhibitory neurons. Glia. 69(10), 2378–2390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7612014</ArticleId>
            <ArticleId IdType="pubmed">34117643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez JJ, Davies HA, Errington ML, Verkhratsky A, Bliss TV, &amp; Stewart MG (2008). ARG3.1/ARC expression in hippocampal dentate gyrus astrocytes: Ultrastructural evidence and co-localization with glial fibrillary acidic protein. Journal of Cellular and Molecular Medicine
12, 671–678.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3822552</ArticleId>
            <ArticleId IdType="pubmed">18419604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez JJ, Davies HA, Silva AT, De Souza IE, Peddie CJ, Colyer FM, … Stewart MG (2005). Long-term potentiation in the rat dentate gyrus is associated with enhanced Arc/Arg3.1 protein expression in spines, dendrites and glia. The European Journal of Neuroscience
21, 2384–2396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15932597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rone MB, Midzak AS, Issop L, Rammouz G, Jagannathan S, Fan J, … Papadopoulos V (2012). Identification of a dynamic mitochondrial protein complex driving cholesterol import, trafficking, and metabolism to steroid hormones. Molecular Endocrinology
26, 1868–1882.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5416962</ArticleId>
            <ArticleId IdType="pubmed">22973050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, … Schumacher M (2010). Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nature Reviews. Drug Discovery
9, 971–988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21119734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sacher C, Blume T, Beyer L, Peters F, Eckenweber F, Sgobio C, … Brendel M (2019). Longitudinal PET monitoring of amyloidosis and microglial activation in a secondgeneration amyloid-beta mouse model. Journal of Nuclear Medicine
60, 1787–1793.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6894380</ArticleId>
            <ArticleId IdType="pubmed">31302633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimoyama S, Furukawa T, Ogata Y, Nikaido Y, Koga K, Sakamoto Y, Ueno S, &amp; Nakamura K (2019). Lipopolysaccharide induces mouse translocator protein (18 kDa) expression via the AP-1 complex in the microglial cell line, BV-2. PLoS One
14, Article e0222861.</Citation>
        </Reference>
        <Reference>
          <Citation>Si Chaib Z, Marchetto A, Dishnica K, Carloni P, Giorgetti A, &amp; Rossetti G (2020). Impact of cholesterol on the stability of monomeric and dimeric forms of the translocator protein TSPO: A molecular simulation study. Molecules
25.</Citation>
        </Reference>
        <Reference>
          <Citation>Stowell RD, Wong EL, Batchelor HN, Mendes MS, Lamantia CE, Whitelaw BS, &amp; Majewska AK (2018). Cerebellar microglia are dynamically unique and survey Purkinje neurons in vivo. Developmental Neurobiology
78, 627–644.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6544048</ArticleId>
            <ArticleId IdType="pubmed">29285893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sucksdorff M, Matilainen M, Tuisku J, Polvinen E, Vuorimaa A, Rokka J, Nylund M, Rissanen E, &amp; Airas L (2020). Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis. Brain
143, 3318–3330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7719021</ArticleId>
            <ArticleId IdType="pubmed">33006604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taketani S, Kohno H, Furukawa T, &amp; Tokunaga R (1995). Involvement of peripheraltype benzodiazepine receptors in the intracellular transport of heme and porphyrins. Journal of Biochemistry
117, 875–880.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7592553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanimoto Y, Yamasaki T, Nagoshi N, Nishiyama Y, Nori S, Nishimura S, … Okano H (2020). In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation. Stem Cells Translational Medicine
9, 465–477.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7103627</ArticleId>
            <ArticleId IdType="pubmed">31904914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tournier BB, Tsartsalis S, Ceyzeriat K, Fraser BH, Gregoire MC, Kovari E, &amp; Millet P (2020). Astrocytic TSPO upregulation appears before microglial TSPO in Alzheimer’s disease. Journal of Alzheimer’s Disease
77, 1043–1056.</Citation>
        </Reference>
        <Reference>
          <Citation>Tournier BB, Tsartsalis S, Ceyzeriat K, Garibotto V, &amp; Millet P (2020). In vivo TSPO signal and neuroinflammation in Alzheimer’s disease. Cells
9.</Citation>
        </Reference>
        <Reference>
          <Citation>Tournier BB, Tsartsalis S, Ceyzeriat K, Medina Z, Fraser BH, Gregoire MC, … Millet P (2020). Fluorescence-activated cell sorting to reveal the cell origin of radioligand binding. Journal of Cerebral Blood Flow and Metabolism
40, 1242–1255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7238369</ArticleId>
            <ArticleId IdType="pubmed">31242048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tournier BB, Tsartsalis S, Rigaud D, Fossey C, Cailly T, Fabis F, … Millet P (2019). TSPO and amyloid deposits in sub-regions of the hippocampus in the 3xTgAD mouse model of Alzheimer’s disease. Neurobiology of Disease
121, 95–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30261283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Troike KM, Acanda de la Rocha AM, Alban TJ, Grabowski MM, Otvos B, Cioffi G, … Azzam DJ (2021). The Translocator Protein (TSPO) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients. Cancers (Basel)
13.</Citation>
        </Reference>
        <Reference>
          <Citation>Tu LN, Morohaku K, Manna PR, Pelton SH, Butler WR, Stocco DM, &amp; Selvaraj V (2014). Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. The Journal of Biological Chemistry
289, 27444–27454.</Citation>
        </Reference>
        <Reference>
          <Citation>Varga B, Marko K, Hadinger N, Jelitai M, Demeter K, Tihanyi K, … Madarasz E (2009). Translocator protein (TSPO 18kDa) is expressed by neural stem and neuronal precursor cells. Neuroscience Letters
462, 257–262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19545604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veenman L, Papadopoulos V, &amp; Gavish M (2007). Channel-like functions of the 18-kDa translocator protein (TSPO): Regulation of apoptosis and steroidogenesis as part of the host-defense response. Current Pharmaceutical Design
13, 2385–2405.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17692008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verma A, Nye JS, &amp; Snyder SH (1987). Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proceedings of the National Academy of Sciences of the United States of America
84, 2256–2260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC304628</ArticleId>
            <ArticleId IdType="pubmed">3031675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vicente-Rodriguez M, Singh N, Turkheimer F, Peris-Yague A, Randall K, Veronese M, … Parker CA (2021). Resolving the cellular specificity of TSPO imaging in a rat model of peripherally-induced neuroinflammation. Brain, Behavior, and Immunity
96, 154–167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8323128</ArticleId>
            <ArticleId IdType="pubmed">34052363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vicidomini C, Guo N, &amp; Sahay A (2020). Communication, cross talk, and signal integration in the adult hippocampal neurogenic niche. Neuron
105, 220–235.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7184932</ArticleId>
            <ArticleId IdType="pubmed">31972145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vo SV, Banister SD, Freelander I, Werry EL, Reekie TA, Ittner LM, &amp; Kassiou M (2020). Reversing binding sensitivity to A147T translocator protein. RSC Med Chem
11, 511–517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7489257</ArticleId>
            <ArticleId IdType="pubmed">33479652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang HJ, Fan J, &amp; Papadopoulos V (2012). Translocator protein (Tspo) gene promoter-driven green fluorescent protein synthesis in transgenic mice: An in vivo model to study Tspo transcription. Cell and Tissue Research
350, 261–275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3740157</ArticleId>
            <ArticleId IdType="pubmed">22868914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang M, Wang X, Zhao L, Ma W, Rodriguez IR, Fariss RN, &amp; Wong WT (2014). Macroglia-microglia interactions via TSPO signaling regulates microglial activation in the mouse retina. The Journal of Neuroscience
34, 3793–3806.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3942591</ArticleId>
            <ArticleId IdType="pubmed">24599476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Werry EL, Bright FM, Piguet O, Ittner LM, Halliday GM, Hodges JR, … Kassiou M (2019). Recent developments in TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders. International Journal of Molecular Sciences
20.</Citation>
        </Reference>
        <Reference>
          <Citation>Wolf A, Herb M, Schramm M, &amp; Langmann T (2020). The TSPO-NOX1 axis controls phagocyte-triggered pathological angiogenesis in the eye. Nature Communications
11, 2709.</Citation>
        </Reference>
        <Reference>
          <Citation>Woods MJ, &amp; Williams DC (1996). Multiple forms and locations for the peripheraltype benzodiazepine receptor. Biochemical Pharmacology
52, 1805–1814.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8951338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamada K, &amp; Watanabe M (2002). Cytodifferentiation of Bergmann glia and its relationship with Purkinje cells. Anatomical Science International
77, 94–108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12418089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yasin N, Veenman L, Singh S, Azrad M, Bode J, Vainshtein A, … Gavish M (2017). Classical and novel TSPO ligands for the mitochondrial TSPO can modulate nuclear gene expression: Implications for mitochondrial retrograde Signaling. International Journal of Molecular Sciences
18.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang L, Hu K, Shao T, Hou L, Zhang S, Ye W, … Liang SH (2021). Recent developments on PET radiotracers for TSPO and their applications in neuroimaging. Acta Pharmaceutica Sinica B
11, 373–393.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7893127</ArticleId>
            <ArticleId IdType="pubmed">33643818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zinnhardt B, Belloy M, Fricke IB, Orije J, Guglielmetti C, Hermann S, … Jacobs AH (2019). Molecular imaging of immune cell dynamics during de- and remyelination in the cuprizone model of multiple sclerosis by [(18)F]DPA-714 PET and MRI. Theranostics
9, 1523–1537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6485187</ArticleId>
            <ArticleId IdType="pubmed">31037121</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
